CALGARY, ALBERTA--(CCNMatthews - Jan. 26, 2005) - Resverlogix Corp. (“Resverlogix”) (TSX:RVX), is pleased to announce the newly formed international research collaboration with leading atherosclerosis researcher Prediman K. Shah, MD. Dr. Shah, is Director of the Division of Cardiology and the Atherosclerosis Research Center at Cedars-Sinai Medical Center, where he holds the Shapell and Webb Family Endowed Chair in Cardiology. Dr. Shah is also Professor of Medicine at the University of California, Los Angeles (UCLA) School of Medicine.
